July 8, 2008
And yet, another filler? Is this the Holy Grail?
Analysis: Just when we thought we have seen every type of soft tissue filler, a new one, Envolence, hits the market. This is not your father's filler, this is a new twist on an old theme, collagen. The most popular fillers today are the hyaluronic acid (HA) fillers, and includes products such as Restylane and Juvederm. These products are easy to use, are reliable, and last about 6 months. Envolence was FDA approved for filling nasolabial folds, and was compared head to head with HA. It lasted as long as the HA fillers, but has the advantage of being a collagen filler, and therefore does not maintain its effect by the absorption of water into the injection site as HA does. It does not require skin testing, even though the older collagen products did. It is dispensed in 1 cc syringes, but needs to be administered using a 27 gauge needle (slightly larger than the HA's, so potentially a bit more painful). I am not sure about the cost comparisons, but if the price is comparable, I give it a big thumbs up.
Report a Concern
More GLG News in
Healthcare
Heart Stents No Better Than Drugs for Chest Pain Over Time
www.bloomberg.com
UK Says Kidney Cancer Drugs Are Too Pricey
www.pharmalot.com
FDA Alert: Hemorrhagic or Necrotizing Pancreatitis in Patients Taking Byetta
www.fda.gov
Abbott signs deal to promote Crestor in U.S.
www.chicagotribune.com
Majority of Patients Want Doc to use EHRs: Study
www.modernhealthcare.com
Byetta sale will reduce after FAD alert
August 19, 2008
Less and less evidence to favor coronary stenting
August 15, 2008
Random finding does justify change in Byetta prescribing
August 11, 2008
Fair or Unfair Decision: the cost of the drugs for kidney cancer is more than the economy can bear.
August 11, 2008
byetta / LAR will be multi-billion dollar drug
August 8, 2008

